PULMONX CORPORATION (LUNG) Operating income 2018–2025
PULMONX CORPORATION (LUNG) annual operating income history from SEC filings — each fiscal year as reported.
-$53.7MFY2025 · since FY2018: -$15.1M → -$53.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$53.7M | +7.0% |
| FY2024 | -$57.7M | +6.8% |
| FY2023 | -$61.9M | -5.6% |
| FY2022 | -$58.6M | -24.0% |
| FY2021 | -$47.3M | -46.3% |
| FY2020 | -$32.3M | -81.3% |
| FY2019 | -$17.8M | -18.5% |
| FY2018 | -$15.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice